| | Cell lineage | Karyotype | Patient 1 | Patient 2 | Patient 3 |
| | Normal | 46,X_ | — | — | 10 (2.0%) | | Monocentric ring | 46,X_,r(13) | 421 (84.2%) | 429 (85.8%) | 421 (84.2%) | | Monosomy 13 | 45,X_,‒13 | 59 (11.8%) | 40 (8.0%) | 46 (9.2%) | | Dicentric ring | 46,X_,dic r(13) | 3 (0.6%) | 21 (4.2%) | 5 (1.0%) | | Monosomy 13 + marker | 46,X_,‒13,+mar | 3 (0.6%) | 3 (0.6%) | 6 (1.2%) | | Deletion 13? | 46,X_,?del(13)(q31) | 1 (0.2%) | — | — | | Isochromosome 13q | 46,X_,i(13)(q10) | — | 1 (0.2%) | — | | Derivative13 | 46,X_,der(13) | 4 (0.8%) | — | — | | Monocentric ring × 2 | 47,X_,r(13) × 2 | 4 (0.8%) |
1 (0.2%) | 4 (0.8%) | | Dicentric ring × 2 | 47,X_,dic r(13) × 2 | 2 (0.4%) | 1 (0.2%) | 1 (0.2%) | | Monocentric ring + dicentric ring | 47,X_,r(13),+dic r(13) | 1 (0.2%) | 2 (0.4%) | 1 (0.2%) | | Monocentric ring + derivative 13 | 47,X_,r(13),+der(13) | 1 (0.2%) | — | — | | Monocentric ring + marker | 47,X_,r(13),+mar | 1 (0.2%) | 1 (0.2%) | 1 (0.2%) | | Dicentric ring + marker 1 + marker 2 | 49,X_,dic r(13),+mar1 × 2,+mar2 | — | 1 (0.2%) | — | | Pulverization | 46,X_,pvz(13) | — | — | 3 (0.6%) | | Monocentric ring + pulverization | 47,X_,r(13),+pvz(13) | — | — | 2 (0.4%) | | N= | 500 | 500 | 500 |
|
|
